| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Stoke Therapeutics, Inc. | 10%+ Owner | Common Stock | 3,906,181 | $39,843,046 | $10.20 | 04 Jun 2025 | Indirect |
| Akero Therapeutics, Inc. | Former 10% owner | Common Stock | 3,271,829 | $2,012,175 | $0.6150 | 01 Dec 2022 | Indirect |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| STOK | Stoke Therapeutics, Inc. | 04 Jun 2025 | 1 | -$30,600,000 | 4 | 10%+ Owner | 06 Jun 2025, 16:20 |
| STOK | Stoke Therapeutics, Inc. | 23 Dec 2024 | 1 | -$23,000,000 | 4 | 10%+ Owner | 27 Dec 2024, 17:13 |
| STOK | Stoke Therapeutics, Inc. | 19 Sep 2024 | 1 | -$27,221,875 | 4 | 10%+ Owner | 23 Sep 2024, 16:23 |
| STOK | Stoke Therapeutics, Inc. | 17 Apr 2024 | 1 | -$41,760,000 | 4 | 10%+ Owner | 18 Apr 2024, 16:16 |
| AKRO | Akero Therapeutics, Inc. | 01 Dec 2022 | 1 | -$71,166,000 | 4 | Former 10% owner | 05 Dec 2022, 15:36 |
| AKRO | Akero Therapeutics, Inc. | 21 Jun 2021 | 0 | $0 | 3 | 10%+ Owner | 30 Jun 2021, 16:16 |
| STOK | Stoke Therapeutics, Inc. | 21 Jun 2021 | 0 | $0 | 3 | 10%+ Owner | 30 Jun 2021, 16:14 |